Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Radley, Gemma"'
Autor:
Radley, Gemma
Ventricular assist devices (VADs) offer long term therapy to chronic heart failure patients who are ineligible for transplant. However, complications such as infection and thrombosis remain characteristic of VAD therapy. Leukocytes contribute to both
Externí odkaz:
https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.752386
Autor:
Radley, Gemma, Pieper, Ina laura, Robinson, Christian R., Ali, Sabrina, Beshr, Mostafa, Bodger, Owen, Thornton, Catherine A.
Publikováno v:
In Journal of Cardiac Failure January 2020 26(1):70-79
Autor:
Radley, Gemma1,2 (AUTHOR), Laura Pieper, Ina1 (AUTHOR), Thomas, Bethan R.1 (AUTHOR), Hawkins, Karl1 (AUTHOR), Thornton, Catherine A.1 (AUTHOR) c.a.thornton@swansea.ac.uk
Publikováno v:
Artificial Organs. Jul2019, Vol. 43 Issue 7, pE139-E151. 13p.
Autor:
Pieper, Ina Laura1,2 i.l.pieper@swansea.ac.uk, Radley, Gemma1,2, Christen, Abigail2, Ali, Sabrina2, Bodger, Owen1, Thornton, Catherine A.1
Publikováno v:
Artificial Organs. Jun2018, Vol. 42 Issue 6, pE78-E89. 12p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Radley, Gemma
Publikováno v:
Radley, G 2018, ' Impact of ventricular assist devices on the activity of white blood cells and the implications for device design testing : Leukocyte response to VADs ', Doctor of Philosophy, Swansea University . https://doi.org/10.23889/SUthesis.40670
Ventricular assist devices (VADs) offer long term therapy to chronic heart failure patients who are ineligible for transplant. However, complications such as infection and thrombosis remain characteristic of VAD therapy.Leukocytes contribute to both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3818::78efdd967f06007f01fe35b61e46b836
https://doi.org/10.23889/SUthesis.40670
https://doi.org/10.23889/SUthesis.40670
Publikováno v:
Radley, G, Pieper, I L, Ali, S, Bhatti, F & Thornton, C A 2018, ' Review: The Inflammatory Response to Ventricular Assist Devices ', Frontiers in Immunology . https://doi.org/10.3389/fimmu.2018.02651
The therapeutic use of ventricular assist devices (VADs) for end-stage heart failure (HF) patients who are ineligible for transplant has increased steadily in the last decade. In parallel, improvements in VAD design have reduced device size, cost, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3818::f2dd9591b81c2b37241dd220add14368
https://www.research.manchester.ac.uk/portal/en/publications/review-the-inflammatory-response-to-ventricular-assist-devices(cd917677-72b7-47ed-b514-aad83323c84a).html
https://www.research.manchester.ac.uk/portal/en/publications/review-the-inflammatory-response-to-ventricular-assist-devices(cd917677-72b7-47ed-b514-aad83323c84a).html
Publikováno v:
Radley, G, Ali, S, Pieper, I L & Thornton, C A 2018, ' Mechanical Shear Stress and Leukocyte Phenotype and Function: Implications for VAD Development and Use ', International Journal of Artificial Organs . https://doi.org/10.1177/0391398818817326
Heart failure (HF) remains a disease of ever increasing prevalence in the modern world. Patients with end-stage HF are being referred increasingly for mechanical circulatory support (MCS). MCS can assist patients who are ineligible for transplant and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3818::6e785673d408abb091c62da4843fb767
https://pure.manchester.ac.uk/ws/files/82757638/Radley_G_IJAO_2018_PureCopy.docx
https://pure.manchester.ac.uk/ws/files/82757638/Radley_G_IJAO_2018_PureCopy.docx
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chan, Chris HH, Pieper, Ina Laura, Hambly, Rebecca, Radley, Gemma, Jones, Alyssa, Friedmann, Yasmin, Hawkins, Karl M, Westaby, Stephen, Foster, Graham, Thornton, Catherine A
Publikováno v:
Artificial Organs
Implantable ventricular assist devices (VADs) have proven efficient in advanced heart failure patients as a bridge-to-transplant or destination therapy. However, VAD usage often leads to infection, bleeding, and thrombosis, side effects attributable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e352bc7a7b4ca68e83ce73cd4cfabad
http://europepmc.org/articles/PMC4338790
http://europepmc.org/articles/PMC4338790